SecBot SecBot
144 ·Filed Jun 5, 2026

HRMY

Harmony Biosciences Holdings, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001950047-26-005696
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small in absolute and relative terms, but the pattern of recent sales by a former officer (7,064 shares on June 4 and 45,481 shares on May 8) suggests ongoing portfolio liquidation. Monitor for additional Form 4 filings or a larger Form 144 that could signal a more significant divestment. No immediate price impact expected.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$32.39
T+0 close · Jun 5, 2026 · via day close
Latest settled
+14.26%
T+20 · $37.01
Vs SPY
+12.63%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · Jun 8 $32.39entry
  2. T+1 · 5mo ago +5.28%α +5.57% · $34.10
  3. T+5 · 5mo ago +5.53%α +3.41% · $34.18
  4. T+20 · 4mo ago +14.26%α +12.63% · $37.01
  5. T+60 · due 3mo ago Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 2,101 shares of Harmony Biosciences (HRMY) with an estimated aggregate market value of approximately $69,504. The shares are to be sold through Morgan Stanley Smith Barney and were acquired via exercise of options under a registered plan. This is a relatively small sale relative to Kapadia's prior reported holdings and the company's $1.9B market cap, but as a former officer filing an intent to sell, it warrants monitoring.

Key Facts

  • Form 144 filed by Sandip Kapadia, a former officer of Harmony Biosciences Holdings, Inc.
  • Proposed sale of 2,101 shares of common stock with an estimated aggregate market value of $69,504.02.
  • Shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
  • Shares acquired via exercise of options under a registered plan on June 5, 2026.
  • Kapadia previously sold 7,064 shares on June 4, 2026, and 45,481 shares on May 8, 2026.
  • The filing is an advance notice of intent to sell; the sale may not be completed.

Financial Impact

Proposed sale of 2,101 shares valued at approximately $69,504, representing a small fraction of the company's $1.9B market cap.

dilutioninsider selling

Risk Factors

  • Insider selling by a former officer may signal lack of confidence or personal liquidity needs, though the amount is small.
  • The filing is an intent to sell; the actual sale may not occur, reducing the signal value.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
65% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005696
Document: 0001950047-26-005696-index.html0001950047-26-005696
Document: 0001950047-26-005696.txt0001950047-26-005696

Track record

20 reports on HRMY

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +14.82% at T+20 after the Jul 16, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
  2. Nov 4, 202612d ago 8-K Bearish 5/10 No price data
  3. Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
  4. Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
  5. Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
  6. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
  7. Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
  9. Aug 4, 202614w ago 8-K Bullish 7/10 No price data
  10. Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
Showing 10 of 20

US Market Status

Market Closed · Opens in 7h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026